- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CTI reports disappointing quarter
Revenues and profits obtained by PET pioneer CTI Molecular Imaging dropped as expected in the third quarter (SCAN 8/16/04). Net revenues were $91.8 million, a 7.5% decline from the same period last year. Net income was $2.7 million, or 6¢ per share on a
Revenues and profits obtained by PET pioneer CTI Molecular Imaging dropped as expected in the third quarter (SCAN 8/16/04). Net revenues were $91.8 million, a 7.5% decline from the same period last year. Net income was $2.7 million, or 6¢ per share on a fully diluted basis, compared with $7.5 million, or 16¢ per share on a fully diluted basis, from the prior fiscal year's third quarter.
During the quarter, CTI sold 33 scanners and booked orders for an additional 42. The company expects the lull in demand to continue until the market absorbs the sharp increase in installed base that has occurred over the past two years.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
